EyePoint (EYPT) Cash & Equivalents (2010 - 2026)
EyePoint (EYPT) recorded Cash & Equivalents of $110.46 million in Q2 2026, up 55.3% from $71.14 million a year earlier and up 42.1% from the prior quarter.
Powered by 
Analysis
EyePoint (EYPT) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, EyePoint reported Cash & Equivalents of $101.82 million, up 2.1% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $99.7 million in FY2024 (-64.6%), $281.26 million in FY2023 (+194.1%), $95.63 million in FY2022 (-46.5%) and $178.59 million in FY2021 (+297.7%).
- The Q2 2026 figure is the highest quarterly Cash & Equivalents since Q1 2024.
- On a year-over-year basis, Cash & Equivalents rose in two of the last eight quarters, with an average decline of 19.1%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 316.7% in Q3 2021, against a decline of 68.6% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $77.71 million (Q1 2026), $101.82 million (Q4 2025) and $74.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | EyePoint | 276.19 Mn | -636.93 Mn | 507,000.00 | 110.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110.46 Mn |
| Mar 31, 2026 | 77.71 Mn |
| Dec 31, 2025 | 101.82 Mn |
| Sep 30, 2025 | 74.58 Mn |
| Jun 30, 2025 | 71.14 Mn |
| Mar 31, 2025 | 85.16 Mn |
| Dec 31, 2024 | 99.70 Mn |
| Sep 30, 2024 | 79.83 Mn |
| Jun 30, 2024 | 90.77 Mn |
| Mar 31, 2024 | 271.01 Mn |
| Dec 31, 2023 | 281.26 Mn |
| Sep 30, 2023 | 133.04 Mn |
| Jun 30, 2023 | 139.60 Mn |
| Mar 31, 2023 | 105.77 Mn |
| Dec 31, 2022 | 95.63 Mn |
| Sep 30, 2022 | 75.36 Mn |
| Jun 30, 2022 | 82.13 Mn |
| Mar 31, 2022 | 101.55 Mn |
| Dec 31, 2021 | 178.59 Mn |
| Sep 30, 2021 | 119.71 Mn |
API Access
EyePoint Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EYPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EYPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EYPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();